CL2014001156A1 - Metodo para reducir el nivel de acido urico en un sujeto con funcion renal dañada administrando un compuesto de formula (i). - Google Patents
Metodo para reducir el nivel de acido urico en un sujeto con funcion renal dañada administrando un compuesto de formula (i).Info
- Publication number
- CL2014001156A1 CL2014001156A1 CL2014001156A CL2014001156A CL2014001156A1 CL 2014001156 A1 CL2014001156 A1 CL 2014001156A1 CL 2014001156 A CL2014001156 A CL 2014001156A CL 2014001156 A CL2014001156 A CL 2014001156A CL 2014001156 A1 CL2014001156 A1 CL 2014001156A1
- Authority
- CL
- Chile
- Prior art keywords
- administering
- subject
- compound
- formula
- level
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2011/059425 WO2013066352A1 (en) | 2011-11-04 | 2011-11-04 | Methods for treating gout in patient subpopulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2014001156A1 true CL2014001156A1 (es) | 2015-01-16 |
Family
ID=48192536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2014001156A CL2014001156A1 (es) | 2011-11-04 | 2014-05-02 | Metodo para reducir el nivel de acido urico en un sujeto con funcion renal dañada administrando un compuesto de formula (i). |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP2775835A4 (es) |
| JP (1) | JP6047172B2 (es) |
| KR (1) | KR101848122B1 (es) |
| CN (1) | CN104066323A (es) |
| AU (1) | AU2011380509B2 (es) |
| BR (1) | BR112014010693A2 (es) |
| CA (1) | CA2859689C (es) |
| CL (1) | CL2014001156A1 (es) |
| IL (1) | IL232385A (es) |
| MX (1) | MX354846B (es) |
| NZ (1) | NZ624714A (es) |
| SG (1) | SG11201402027PA (es) |
| WO (1) | WO2013066352A1 (es) |
| ZA (1) | ZA201403574B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015512948A (ja) * | 2012-04-13 | 2015-04-30 | サイマベイ・セラピューティクス・インコーポレイテッドＣｙｍａＢａｙ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． | ハロフェナートまたはハロフェン酸および抗炎症剤を用いる痛風に罹っている患者の高尿酸血症の治療方法 |
| CN106036135A (zh) * | 2014-07-25 | 2016-10-26 | 许伟琦 | 一种防止结石、快速排结石的药物、组合物、兽药 |
| CN105920022A (zh) * | 2016-05-12 | 2016-09-07 | 成都易创思生物科技有限公司 | 一种抗痛风药物复方制剂 |
| JP7086980B2 (ja) * | 2017-10-26 | 2022-06-20 | 大塚製薬株式会社 | イノシトールリン酸含有組成物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4250191A (en) * | 1978-11-30 | 1981-02-10 | Edwards K David | Preventing renal failure |
| US6262118B1 (en) * | 1999-06-04 | 2001-07-17 | Metabolex, Inc. | Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia |
| CN103058944B (zh) * | 2007-11-27 | 2015-08-05 | 亚德生化公司 | 调节血液尿酸水平的化合物 |
-
2011
- 2011-11-04 AU AU2011380509A patent/AU2011380509B2/en not_active Ceased
- 2011-11-04 KR KR1020147015209A patent/KR101848122B1/ko active IP Right Grant
- 2011-11-04 CA CA2859689A patent/CA2859689C/en not_active Expired - Fee Related
- 2011-11-04 MX MX2014005399A patent/MX354846B/es active IP Right Grant
- 2011-11-04 NZ NZ624714A patent/NZ624714A/en not_active IP Right Cessation
- 2011-11-04 CN CN201180076189.7A patent/CN104066323A/zh active Pending
- 2011-11-04 EP EP11875027.2A patent/EP2775835A4/en not_active Withdrawn
- 2011-11-04 WO PCT/US2011/059425 patent/WO2013066352A1/en active Application Filing
- 2011-11-04 JP JP2014541012A patent/JP6047172B2/ja not_active Expired - Fee Related
- 2011-11-04 SG SG11201402027PA patent/SG11201402027PA/en unknown
- 2011-11-04 BR BR112014010693-2A patent/BR112014010693A2/pt not_active IP Right Cessation
-
2014
- 2014-04-30 IL IL232385A patent/IL232385A/en active IP Right Grant
- 2014-05-02 CL CL2014001156A patent/CL2014001156A1/es unknown
- 2014-05-16 ZA ZA2014/03574A patent/ZA201403574B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2859689A1 (en) | 2013-05-10 |
| AU2011380509A1 (en) | 2014-05-29 |
| CN104066323A (zh) | 2014-09-24 |
| KR101848122B1 (ko) | 2018-04-11 |
| ZA201403574B (en) | 2015-11-25 |
| MX2014005399A (es) | 2015-04-08 |
| JP2014532759A (ja) | 2014-12-08 |
| EP2775835A4 (en) | 2015-07-29 |
| IL232385A (en) | 2017-10-31 |
| IL232385A0 (en) | 2014-06-30 |
| WO2013066352A1 (en) | 2013-05-10 |
| BR112014010693A2 (pt) | 2020-11-10 |
| EP2775835A1 (en) | 2014-09-17 |
| KR20140123927A (ko) | 2014-10-23 |
| AU2011380509B2 (en) | 2016-05-19 |
| SG11201402027PA (en) | 2014-09-26 |
| MX354846B (es) | 2018-03-22 |
| JP6047172B2 (ja) | 2016-12-21 |
| CA2859689C (en) | 2018-05-22 |
| NZ624714A (en) | 2016-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL231828A0 (en) | Formulations of ethenecept stabilized with xylitol | |
| ZA201404461B (en) | Process to prepare levulinic acid | |
| IL227754B (en) | Analogues of 4-hydroxybutyric acid with deuterium | |
| CL2014002622A1 (es) | Un metodo para modificar beta-estuco utilizando acido dietilen-triamin-pentaacetico. | |
| DK2390914T3 (da) | Indretning af to forbindelsespartnere med en lavtemperatur-tryksinterforbindelse samt fremgangsmåde til dens fremstilling | |
| DK2771475T3 (da) | Fremgangsmåde til omdannelse af lignocellulose til en organisk syre med recycling af opløste salte | |
| EP2682409A4 (en) | BY AMINOCARBOXYLIC ACID MODIFIED HYALURONIC ACID DERIVATIVE | |
| BR112013031365A2 (pt) | método para produzir um composto | |
| DK3351546T3 (da) | Langtidsvirkende injicerbare moxidectinformuleringer | |
| HK1185947A1 (zh) | 作為呋咱並苯並咪唑類藥物應答的生物標記的用途 | |
| CL2014001156A1 (es) | Metodo para reducir el nivel de acido urico en un sujeto con funcion renal dañada administrando un compuesto de formula (i). | |
| HK1201067A1 (en) | Sialic acid analogs | |
| SMT201600199B (it) | Perfezionamenti relativi a pompe per pene | |
| FR2974862B1 (fr) | Pompe a engrenage | |
| HK1199033A1 (en) | Sulfonic acid salts of heterocyclylamide-substituted imidazoles | |
| SMT201600071B (it) | Derivato di acido pirrolidina-3-ilacetico | |
| BR112013015002A2 (pt) | método para obter um composto | |
| BR112014025158A2 (pt) | método para produzir um composto. | |
| CO6811871A2 (es) | Proceso para la cristalización de un compuesto soluble en agua | |
| EP2768812A4 (en) | BOSENTAN ACID ADDITION SALTS | |
| BR112013015003A2 (pt) | método para obter um composto | |
| AU2014200986B2 (en) | 4-hydroxybutyric acid analogs | |
| AU2011200745B2 (en) | 4-hydroxybutyric acid analogs | |
| PL395854A1 (pl) | Sposób redukcji ilosci balastu na statkach | |
| UA22917S (uk) | Комплект етикеток для горілки «forel' royal» |